{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T18:03:52Z","timestamp":1791050632506,"version":"4.1.0"},"reference-count":42,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2010,10,1]],"date-time":"2010-10-01T00:00:00Z","timestamp":1285891200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Atherosclerosis"],"published-print":{"date-parts":[[2010,10]]},"DOI":"10.1016\/j.atherosclerosis.2010.06.006","type":"journal-article","created":{"date-parts":[[2010,6,12]],"date-time":"2010-06-12T08:34:26Z","timestamp":1276331666000},"page":"607-613","source":"Crossref","is-referenced-by-count":48,"title":["Acute infection with Epstein\u2013Barr virus is associated with atherogenic lipid changes"],"prefix":"10.1016","volume":"212","author":[{"given":"F.","family":"Apostolou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"I.F.","family":"Gazi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K.","family":"Lagos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.C.","family":"Tellis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.D.","family":"Tselepis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.N.","family":"Liberopoulos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Elisaf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.atherosclerosis.2010.06.006_bib1","doi-asserted-by":"crossref","first-page":"780","DOI":"10.3201\/eid0705.010503","article-title":"Potential infectious etiologies of atherosclerosis: a multifactorial perspective","volume":"7","author":"O\u2019Connor","year":"2001","journal-title":"Emerg Infect Dis"},{"key":"10.1016\/j.atherosclerosis.2010.06.006_bib2","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1194\/jlr.R300019-JLR200","article-title":"Effects of infection and inflammation on lipid and lipoprotein metabolism: mechanisms and consequences to the host","volume":"45","author":"Khovidhunkit","year":"2004","journal-title":"J Lipid Res"},{"key":"10.1016\/j.atherosclerosis.2010.06.006_bib3","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/j.bbalip.2009.02.015","article-title":"The role of lipoprotein-associated phospholipase A2 in atherosclerosis may depend on its lipoprotein carrier in plasma","volume":"1791","author":"Tellis","year":"2009","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.atherosclerosis.2010.06.006_bib4","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1007\/s10557-008-6135-6","article-title":"Lipoprotein-associated and secretory phospholipase A2 in cardiovascular disease: the epidemiological evidence","volume":"23","author":"Koenig","year":"2009","journal-title":"Cardiovasc Drugs Ther"},{"key":"10.1016\/j.atherosclerosis.2010.06.006_bib5","first-page":"R94","article-title":"In vivo regulation of plasma platelet-activating factor acetylhydrolase during the acute phase response","volume":"277","author":"Memon","year":"1999","journal-title":"Am J Physiol"},{"key":"10.1016\/j.atherosclerosis.2010.06.006_bib6","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1080\/09629350020002921","article-title":"Platelet-activating factor acetylhydrolase and haemophagocytosis in the sepsis syndrome","volume":"9","author":"Trimoreau","year":"2000","journal-title":"Mediat Inflamm"},{"key":"10.1016\/j.atherosclerosis.2010.06.006_bib7","doi-asserted-by":"crossref","first-page":"1524","DOI":"10.1016\/S0026-0495(99)90240-8","article-title":"Plasma platelet-activating factor acetylhydrolase activity in human immunodeficiency virus infection and the acquired immunodeficiency syndrome","volume":"48","author":"Khovidhunkit","year":"1999","journal-title":"Metabolism"},{"key":"10.1016\/j.atherosclerosis.2010.06.006_bib8","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/S1567-5688(02)00046-6","article-title":"Paraoxonase and coronary heart disease","volume":"3","author":"Mackness","year":"2002","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.atherosclerosis.2010.06.006_bib9","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1194\/jlr.M200432-JLR200","article-title":"Serum paraoxonase: effect of the apolipoprotein composition of HDL and the acute phase response","volume":"44","author":"Cabana","year":"2003","journal-title":"J Lipid Res"},{"key":"10.1016\/j.atherosclerosis.2010.06.006_bib10","doi-asserted-by":"crossref","first-page":"2532","DOI":"10.1194\/jlr.P900063-JLR200","article-title":"Persistence of an atherogenic lipid profile after treatment of acute infection with brucella","volume":"50","author":"Apostolou","year":"2009","journal-title":"J Lipid Res"},{"key":"10.1016\/j.atherosclerosis.2010.06.006_bib11","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1517\/14712598.7.1.53","article-title":"Clinical importance and therapeutic modulation of small dense low-density lipoprotein particles","volume":"7","author":"Gazi","year":"2007","journal-title":"Expert Opin Biol Ther"},{"key":"10.1016\/j.atherosclerosis.2010.06.006_bib12","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/S0021-9150(03)00058-3","article-title":"Decrease in LDL size in HIV-positive adults before and after lopinavir\/ritonavir-containing regimen: an index of atherogenicity?","volume":"168","author":"Badiou","year":"2003","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.atherosclerosis.2010.06.006_bib13","doi-asserted-by":"crossref","first-page":"2752","DOI":"10.1194\/jlr.M500389-JLR200","article-title":"Altered lipoprotein subclass distribution and PAF-AH activity in subjects with generalized aggressive periodontitis","volume":"46","author":"Rufail","year":"2005","journal-title":"J Lipid Res"},{"key":"10.1016\/j.atherosclerosis.2010.06.006_bib14","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/S1473-3099(03)00543-7","article-title":"Epstein\u2013Barr virus-recent advances","volume":"3","author":"Macsween","year":"2003","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.atherosclerosis.2010.06.006_bib15","doi-asserted-by":"crossref","first-page":"1764","DOI":"10.1161\/01.ATV.15.10.1764","article-title":"PAF-degrading acetylhydrolase is preferentially associated with dense LDL and VHDL-1 in human plasma. Catalytic characteristics and relation to the monocyte-derived enzyme","volume":"15","author":"Tselepis","year":"1995","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.atherosclerosis.2010.06.006_bib16","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1177\/089686080402400618","article-title":"Alterations of paraoxonase and platelet-activating factor acetylhydrolase activities in patients on peritoneal dialysis","volume":"24","author":"Liberopoulos","year":"2004","journal-title":"Perit Dial Int"},{"key":"10.1016\/j.atherosclerosis.2010.06.006_bib17","doi-asserted-by":"crossref","first-page":"2264","DOI":"10.1373\/clinchem.2005.058404","article-title":"Lipoprotein-associated phospholipase A2 activity is a marker of small, dense LDL particles in human plasma","volume":"51","author":"Gazi","year":"2005","journal-title":"Clin Chem"},{"key":"10.1016\/j.atherosclerosis.2010.06.006_bib18","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1161\/01.RES.0000037427.73184.C1","article-title":"Advice on statistical analysis for circulation research","volume":"91","author":"Kusuoka","year":"2002","journal-title":"Circ Res"},{"key":"10.1016\/j.atherosclerosis.2010.06.006_bib19","doi-asserted-by":"crossref","first-page":"2581","DOI":"10.1161\/01.STR.0000034789.82859.A4","article-title":"Impact of infectious burden on progression of carotid atherosclerosis","volume":"33","author":"Espinola-Klein","year":"2002","journal-title":"Stroke"},{"key":"10.1016\/j.atherosclerosis.2010.06.006_bib20","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1161\/hc0102.101362","article-title":"Impact of infectious burden on extent and long-term prognosis of atherosclerosis","volume":"105","author":"Espinola-Klein","year":"2002","journal-title":"Circulation"},{"key":"10.1016\/j.atherosclerosis.2010.06.006_bib21","doi-asserted-by":"crossref","first-page":"1966","DOI":"10.1161\/01.CIR.0000064895.89033.97","article-title":"Absence of association between infectious agents and endothelial function in healthy young men","volume":"107","author":"Khairy","year":"2003","journal-title":"Circulation"},{"key":"10.1016\/j.atherosclerosis.2010.06.006_bib22","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1097\/01.CCM.0000059724.08290.51","article-title":"Lipoprotein metabolism in patients with severe sepsis","volume":"31","author":"van Leeuwen","year":"2003","journal-title":"Crit Care Med"},{"key":"10.1016\/j.atherosclerosis.2010.06.006_bib23","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1515\/CCLM.2002.048","article-title":"Serum cholesterol levels in neutropenic patients with fever","volume":"40","author":"Fraunberger","year":"2002","journal-title":"Clin Chem Lab Med"},{"key":"10.1016\/j.atherosclerosis.2010.06.006_bib24","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1210\/jc.74.5.1045","article-title":"Lipids, lipoproteins, triglyceride clearance, and cytokines in human immunodeficiency virus infection and the acquired immunodeficiency syndrome","volume":"74","author":"Grunfeld","year":"1992","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.atherosclerosis.2010.06.006_bib25","doi-asserted-by":"crossref","first-page":"1777","DOI":"10.1161\/01.ATV.20.7.1777","article-title":"Interleukin-6 stimulates LDL receptor gene expression via activation of sterol-responsive and Sp1 binding elements","volume":"20","author":"Gierens","year":"2000","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"suppl. 1","key":"10.1016\/j.atherosclerosis.2010.06.006_bib26","first-page":"66","article-title":"Beneficial effects of cytokine induced hyperlipidemia","volume":"37","author":"Feingold","year":"1998","journal-title":"Z Ernahrungswiss"},{"key":"10.1016\/j.atherosclerosis.2010.06.006_bib27","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1097\/00075197-200303000-00006","article-title":"Apolipoprotein and apolipoprotein receptor genes, blood lipids and disease","volume":"6","author":"Ribalta","year":"2003","journal-title":"Curr Opin Clin Nutr Metab Care"},{"key":"10.1016\/j.atherosclerosis.2010.06.006_bib28","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1161\/01.ATV.20.4.1137","article-title":"Major reduction in plasma Lp(a) levels during sepsis and burns","volume":"20","author":"Mooser","year":"2000","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.atherosclerosis.2010.06.006_bib29","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1136\/jcp.53.7.487","article-title":"Lipoprotein (a) and stroke","volume":"53","author":"Milionis","year":"2000","journal-title":"J Clin Pathol"},{"key":"10.1016\/j.atherosclerosis.2010.06.006_bib30","doi-asserted-by":"crossref","first-page":"984","DOI":"10.1161\/01.ATV.18.6.984","article-title":"Dominant negative effect of TGF-beta1 and TNF-alpha on basal and IL-6-induced lipoprotein(a) and apolipoprotein(a) mRNA expression in primary monkey hepatocyte cultures","volume":"18","author":"Ramharack","year":"1998","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.atherosclerosis.2010.06.006_bib31","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1016\/j.metabol.2006.02.015","article-title":"Concentration and relative distribution of low-density lipoprotein subfractions in patients with metabolic syndrome defined according to the National Cholesterol Education Program criteria","volume":"55","author":"Gazi","year":"2006","journal-title":"Metabolism"},{"key":"10.1016\/j.atherosclerosis.2010.06.006_bib32","doi-asserted-by":"crossref","first-page":"2758","DOI":"10.1172\/JCI118345","article-title":"Anti-inflammatory HDL becomes pro-inflammatory during the acute phase response. Loss of protective effect of HDL against LDL oxidation in aortic wall cell cocultures","volume":"96","author":"Van Lenten","year":"1995","journal-title":"J Clin Invest"},{"key":"10.1016\/j.atherosclerosis.2010.06.006_bib33","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/S0021-9150(98)00084-7","article-title":"Paraoxonase activity in the serum and hepatic mRNA levels decrease during the acute phase response","volume":"139","author":"Feingold","year":"1998","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.atherosclerosis.2010.06.006_bib34","doi-asserted-by":"crossref","first-page":"2283","DOI":"10.1161\/01.CIR.103.18.2283","article-title":"High-density lipoprotein loses its anti-inflammatory properties during acute influenza a infection","volume":"103","author":"Van Lenten","year":"2001","journal-title":"Circulation"},{"key":"10.1016\/j.atherosclerosis.2010.06.006_bib35","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1161\/01.RES.0000064502.47539.6D","article-title":"Endothelial cells secrete triglyceride lipase and phospholipase activities in response to cytokines as a result of endothelial lipase","volume":"92","author":"Jin","year":"2003","journal-title":"Circ Res"},{"key":"10.1016\/j.atherosclerosis.2010.06.006_bib36","doi-asserted-by":"crossref","first-page":"1254","DOI":"10.1016\/S0022-2275(20)41133-2","article-title":"Endotoxin and TNF lead to reduced plasma LCAT activity and decreased hepatic LCAT mRNA levels in Syrian hamsters","volume":"36","author":"Ly","year":"1995","journal-title":"J Lipid Res"},{"key":"10.1016\/j.atherosclerosis.2010.06.006_bib37","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/S0300-2977(01)00144-9","article-title":"The role of high density lipoprotein in sepsis","volume":"59","author":"van Leeuwen","year":"2001","journal-title":"Neth J Med"},{"key":"10.1016\/j.atherosclerosis.2010.06.006_bib38","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1016\/S0140-6736(08)61076-4","article-title":"Lipids, lipoproteins, and apolipoproteins as risk markers of myocardial infarction in 52 countries (the INTERHEART study): a case-control study","volume":"372","author":"McQueen","year":"2008","journal-title":"Lancet"},{"key":"10.1016\/j.atherosclerosis.2010.06.006_bib39","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1007\/s11745-007-3050-8","article-title":"Plasma lipoproteins and triacylglycerol are predictors of small, dense LDL particles","volume":"42","author":"Tsimihodimos","year":"2007","journal-title":"Lipids"},{"key":"10.1016\/j.atherosclerosis.2010.06.006_bib40","doi-asserted-by":"crossref","first-page":"7351","DOI":"10.3748\/wjg.v11.i46.7351","article-title":"Serum arylesterase and paraoxonase activity in patients with chronic hepatitis","volume":"11","author":"Kilic","year":"2005","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.atherosclerosis.2010.06.006_bib41","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/j.atherosclerosis.2006.07.024","article-title":"Serum paraoxonase-1 activity and concentration are influenced by human immunodeficiency virus infection","volume":"194","author":"Parra","year":"2007","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.atherosclerosis.2010.06.006_bib42","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1016\/j.atherosclerosis.2006.10.024","article-title":"Serum paraoxonase-1 activity in Helicobacter pylori infected subjects","volume":"196","author":"Aslan","year":"2008","journal-title":"Atherosclerosis"}],"container-title":["Atherosclerosis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021915010004247?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021915010004247?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2021,10,29]],"date-time":"2021-10-29T10:53:10Z","timestamp":1635504790000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0021915010004247"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,10]]},"references-count":42,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2010,10]]}},"alternative-id":["S0021915010004247"],"URL":"https:\/\/doi.org\/10.1016\/j.atherosclerosis.2010.06.006","relation":{},"ISSN":["0021-9150"],"issn-type":[{"value":"0021-9150","type":"print"}],"subject":[],"published":{"date-parts":[[2010,10]]}}}